A twenty-two-year-old student with hypoplastic anemia was treated with large doses of anabolic steroid hormone preparations for two months. Cerebral hemorrhagic infarction shown by CAT scan developed when his hematologic conditions were improving. In treating hypoplastic anemia with anabolic steroid hormone preparations, one should be aware of the possible development of ce rebral hemorrhagic infarction at the time of hematologic improvement.
Get full access to this article
View all access options for this article.
References
1.
Kennedy BJ, Yarbro JW: Effect of methenolone enanthate (NSC-64967) in advanced cancer of the breast . Cancer21:197-201, 1968.
2.
Shiozawa Z., Yamada H., Mabuchi C., et al: Superior sagittal sinus thrombosis associated with androgen therapy for hypoplastic anemia. Ann Neurol12:578-580, 1982.
3.
Shahidi NT, Diamond LK: Testosterone-induced remission in aplastic anemia. Am J Dis Child98:293-302, 1959.
4.
Sanchez-Medal L., Pizzto J., Torre-Lopez E., et al: Effect of oxymetholone in refractory anemia. Arch Intern Med113:721-729, 1964.
5.
Alexanian R. , Nadell J., Alfrey C.: Oxymetholone treatment for the anemia of bone marrow failure. Blood40:353-356, 1972.
6.
Hirota Y., Hibino S.: Effect of androstanes on aplastic anemia in Japanese. In: International Symposium on Aplastic Anemia, ed. by Hibino S.Kyoto, Japan, Japanese Medical Research Foundation, University Park Press, 1978 , pp. 377-383.
7.
Shahidi NT, Diamond LK: Testosterone-induced remission in aplastic anemia of both acquired and congenital types. Further observation in 24 cases. New Engl J Med264:953-967, 1961.
8.
Najean Y., Pecking A., Le Danvic M.: Androgen therapy of aplastic anemia—a prospective study of 352 cases . Scand J Haematol22:343-356, 1979.
9.
Szontagh FE: The relationship between chemical structure and gestagenic, oestogenic, androgenic, and anabolic properties. Different gestagenic norsteroids. In: Mechanism of Action of Oral Progestogens. Budapest, Akademiai Kiado, 1970, pp. 23-28.
10.
Silverstein A.: Intracranial hemorrhage in patients with bleeding tendencies. Neurology (Minneap)11:310-317, 1961.
11.
Fearnley GR , Chakrabarti R.: Increase of blood fibrinolytic activity by testosterone. Lancet2:128-132, 1962.
12.
Sanchez-Medal L.: The hemopoietic action of androstanes. Prog Hematol8:111-136, 1971.
13.
Shinohara K. , Matsumoto N., Tajiri M., et al: Oxymetholone treatment in aplastic anemia. Acta Haematol Jap37:255-265, 1974.
14.
Novak E., Hendrix JW, Seckman CE, et al: A pharmacologic evaluation of fluoxymesterone in normal men . Curr Ther Res16:251-260, 1974.
15.
Naftolin F. , Ryan KJ, Petro Z.: Aromatization of androstenedione by the anterior hypothalamus of adult male and female rats. Endocrinology90:295-298, 1972.
16.
Edman CD, Aiman EJ, Porter JC, et al: Identification of the estrogen product of extraglandular aromatization of plasma androstenedione. Am J Obstet Gynecol130:439-447, 1978.
Yagge J., Brody S., Korsan-Bengtsen K., et al: Changes in blood coagulation and fibrinolysis in women receiving oral contraceptives. Comparison between treated and untreated women in a longitudinal study. Am J Obstet Gynecol104:87-98, 1969.
19.
Irey NS, Manion WC, Taylor HB: Vascular lesions in women taking oral contraceptives. Arch Pathol89:1-8, 1970.
20.
Poltera AA: The pathology of intracranial venous thrombosis in oral contraception. J Pathol106:209-219, 1972.
21.
Buchanan DS , Brazinsky JH: Dural sinus and cerebral venous thrombosis. Incidence in young women receiving oral contraceptives. Arch Neurol22:440-444, 1970.
22.
Vessey MP, Doll R.: Investigation of relation between use of oral contraceptives and thromboembolic disease. Br Med J2:199-205, 1968.
23.
Weisz J., Gibbs C.: Conversion of testosterone and androstenedione to estrogens in vitro by the brain of female rats. Endocrinology94:616-620, 1974.
Shende MC, Lourie H.: Sagittal sinus thrombosis related to oral contraceptives. Case report. J Neurosurg33:714-717, 1970.
26.
Shiozawa Z. , Ueda R., Mano T., et al: Superior sagittal sinus thrombosis associated with Evans' syndrome of haemolytic anemia. J Neurol232:280-282, 1985.
